TD SYNNEX (SNX) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
20 Dec, 2025Executive summary
Q1/FQ1 FY25 non-GAAP gross billings reached $20.7 billion, up 7.5–8% year-over-year, with broad-based growth across all regions and major technologies.
Revenue rose 4% year-over-year to $14.5–$14.53 billion, driven by Endpoint and Advanced Solutions portfolios.
Non-GAAP diluted EPS was $2.80 (down from $2.99), and GAAP diluted EPS was $1.98 (up from $1.93), both within guidance.
Strategic technologies accounted for 26% of non-GAAP gross billings, with double-digit growth in cloud, cybersecurity, and data analytics.
Returned $138 million to shareholders via $101 million in share repurchases and $37 million in dividends; dividend per share increased 10% year-over-year.
Financial highlights
Gross profit was $998 million, with gross margin at 6.87% (4.82% of non-GAAP gross billings), down year-over-year due to product mix and Hyve.
Non-GAAP operating income was $399 million (1.92% of gross billings), and non-GAAP net income was $237 million.
Free cash flow was negative $790–800 million, mainly due to working capital and Hyve inventory.
Cash and cash equivalents ended at $541.9–$542 million; total borrowings increased to $4.3 billion.
Adjusted ROIC for Q1 was 9.7%; cash conversion cycle increased to 27 days.
Outlook and guidance
Q2/FQ2 2025 non-GAAP gross billings expected between $19.7–$20.7 billion; revenue guidance $13.9–$14.7 billion.
Non-GAAP net income guidance: $205–$247 million; non-GAAP diluted EPS: $2.45–$2.95.
Dividend of $0.44 per share declared, payable April 25, 2025.
Fiscal 2025 targets mid-single-digit gross billings growth and $1.1 billion free cash flow.
Management expects sufficient liquidity for at least the next twelve months.
Latest events from TD SYNNEX
- Key votes include director elections, say-on-pay, auditor ratification, and a charter amendment.SNX
Proxy Filing13 Feb 2026 - Proxy covers director elections, say-on-pay, auditor ratification, and ESG progress.SNX
Proxy Filing13 Feb 2026 - Board seeks approval for director elections, executive pay, auditor ratification, and expanded shareholder rights.SNX
Proxy Filing3 Feb 2026 - Q2 delivered 3% gross billings growth, margin gains, and strong shareholder returns.SNX
Q2 20243 Feb 2026 - Q3 non-GAAP gross billings up 9% to $20.3B; revenue $14.7B; Q4 outlook strong.SNX
Q3 202420 Jan 2026 - Q4 revenue rose 10% with strong cash flow, robust capital returns, and a higher dividend.SNX
Q4 202410 Jan 2026 - Record Q4 and FY results with 15% billings growth, 24% EPS gain, and strong FY26 outlook.SNX
Q4 20258 Jan 2026 - Board recommends FOR all management proposals and AGAINST lowering the special meeting threshold.SNX
Proxy Filing1 Dec 2025 - Proxy covers director elections, governance reforms, and strong financial and ESG performance.SNX
Proxy Filing1 Dec 2025